Ndlovu, BDe Kock, MKlaasen, J2021-05-032021-05-032021Ndlovu, B. et al. (2021). In vitro comparison of the anti-proliferative effects of galenia africana on human skin cell lines. Scientia Pharmaceutica, 89(1),12, 1-110036-870910.3390/scipharm89010012http://hdl.handle.net/10566/6124Malignant melanoma is the major cause of skin cancer-related deaths. Surgery in combina-tion with radiotherapy, immunotherapy or chemotherapy is used to eradicate cancer cells, however, this treatment option is limited by the tolerance of the surrounding healthy tissue. The extracts from Galenia africana have been shown to possess anti-cancer flavonoid compounds and can be a safer and cost-effective alternative treatment. The study aimed to compare the anti-proliferative effects of G. africana on human skin cells (HaCaT) and human malignant melanoma cells (A375). The cells were exposed to various concentrations of the G. africana extract at different times. In vitro assays were employed to determine cell viability and cytotoxicity. Hoechst 33342 staining was performed to observe the nuclear changes, including apoptosis. G. africana significantly reduced the cell viability of the A375 cells in a dose and time-dependent manner, while having no effect on the HaCaT cells. The A375 cells displayed nuclear condensation, brightly stained nuclei and nuclear fragmentation indicative of apoptosis.enAnti-proliferationCytotoxicityGalenia africanaSkin cancerHaCaTArticle